The eye melanoma global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Eye Melanoma Market, 2024 report by The Business Research Company offers
comprehensive insights into the current state of the market and highlights
future growth opportunities.
Market Size -
The eye melanoma market size has grown strongly in recent years. It will grow
from $8.29 billion in 2023 to $9.1 billion in 2024 at a compound annual growth
rate (CAGR) of 9.8%. The growth in the historic period can be attributed to
increased awareness and early detection, aging population and sun exposure,
rise in skin cancer incidence, development of targeted therapies, patient
advocacy and support programs..
The eye melanoma market size is expected to see strong growth in the next few
years. It will grow to $12.61 billion in 2028 at a compound annual growth rate
(CAGR) of 8.5%. The growth in the forecast period can be attributed to
continued public health initiatives, research in genetic and molecular
profiling, global aging population trends.. Major trends in the forecast period
include integration of artificial intelligence (ai), emergence of targeted
therapies, focus on rare disease drug development, patient-centric drug
approval processes, advancements in diagnostic imaging, advancements in
treatment modalities, technological innovations in imaging..
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/eye-melanoma-global-market-report
Scope Of Eye Melanoma Market
The Business Research Company's reports encompass a wide range of information,
including:
1. Market Size (Historic and Forecast): Analysis of the market's historical
performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market
landscape.
4. Key Segments: Breakdown of the market into its primary segments and their
respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and
geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting
the market.
Eye Melanoma Market Overview
Market Drivers -
The increasing prevalence of eye cancer is expected to propel the growth of the
eye melanoma market going forward. Eye cancer refers to the development of
abnormal and uncontrolled cell growth within the eye's structures. The growing
recognition and effective management of early cases are creating a heightened
need for specialized therapies and interventions, propelled by improved
detection methods, increased awareness, and advancements in treatment options.
For instance, in January 2023, according to the American Cancer Society, a
US-based nonprofit cancer advocacy organization, the number of eye and orbital
cancer cases increased to 3,490 in 2023, reflecting a growth of 5.12% from
3,320 in 2021. Therefore, the increasing prevalence of eye cancer will drive
the growth of the eye melanoma market.
Market Trends -
Major companies operating in the eye melanoma treatment sector are focused on
developing innovative and specialized treatments, such as immunotherapies and
targeted therapies, to enhance patient outcomes and quality of life.
Immunotherapies and targeted therapies are novel treatment modalities that have
recently begun to enter the oncology field. For instance, in January 2022,
Immunocore Ltd., a UK-based biopharmaceutical company that focuses on research
and development of biological drugs using soluble T-cell receptor technology,
received approval from the U.S. Food and Drug Administration (FDA) for Kimmtrak
(tebentafusp-tabn), a T-cell receptor therapeutic, which is the first therapy for
individuals with unresectable or metastatic uveal melanoma (mUM). Kimmtrak is
an immunotherapy that targets a specific protein called gp100, which is present
on the surface of uveal melanoma (UM) cells. It activates the patient's immune
system to eliminate melanoma by engaging specialized immune cells through
engineered T-cell receptors, offering a precision-driven approach to cancer
treatment.
The eye melanoma market covered in this report is segmented –
1) By Site: Uvea, Sclera, Retina
2) By Diagnosis: Imaging, Biopsy, Eye Exam
3) By Treatment: Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy,
Other Treatment
4) By End User: Hospitals And Clinics, Academic Institutes
Get an inside scoop of the eye melanoma market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13109&type=smp
Regional Insights -
North America was the largest region in the eye melanoma market in 2023.
Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The regions covered in the eye melanoma market report are Asia-Pacific, Western
Europe, Eastern Europe, North America, South America, Middle East, Africa
Key Companies -
Major companies operating in the eye melanoma market report are Pfizer Inc.,
Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc, AbbVie
Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC,
Sanofi S.A., GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc.,
Koninklijke Philips N.V., Carl Zeiss AG, Genentech Inc., Elekta Instrument AB,
Brainlab AG, Optos Plc , Castle Biosciences Inc., Heidelberg Engineering,
Nektar Therapeutics, RaySearch Laboratories AB, Nidek Co. Ltd, IDEAYA
Biosciences, Immunocore Limited , Topcon Healthcare, Oraya Therapeutics Inc.,
Delcath Systems Inc.
Table of Contents
1. Executive Summary
2. Eye Melanoma Market Report Structure
3. Eye Melanoma Market Trends And Strategies
4. Eye Melanoma Market – Macro Economic Scenario
5. Eye Melanoma Market Size And Growth
…..
27. Eye Melanoma Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment